Contact
Please use this form to send email to PR contact of this press release:
ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2
TO:
Please use this form to send email to PR contact of this press release:
ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2
TO: